Manamtam, Mizpha Bianca T.

HRN: 26-98-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2025
CEFUROXIME 1.5GM (VIAL)
05/02/2025
05/03/2025
IV
1.5 GMS
ON CALL TO OR THEN Q 8HRS
NKA
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: